Navigation Links
SuperNova Diagnostics® to Present at the Rodman & Renshaw Global Investment Conference
Date:9/6/2011

WASHINGTON, LONDON and HONG KONG, Sept. 6, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, today announced that Neil J. Campbell, President and CEO, will be presenting at the Rodman & Renshaw Global Investment Conference on September 13, 2011 from 10:50 -11:15 am EDT in the Metropolitan West room of the Waldorf-Astoria in New York, NY.

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology targeting four industry sectors: human health, animal health, industrial and biodefence/biosecurity.  A live webcast and 90 day archive of the presentation will be available at http://www.wsw.com/webcast/rrshq20/spdi.

"Point-of-care and point-of-use diagnostics represent a multi-billion dollar market with an annual growth rate of 20 percent, making it one of the most significant investing and technological opportunities over the next five to 10 years," said Mr. Campbell. "SuperNova is at the forefront of this revolution, having developed our AmpCrystal® platform to provide an array of diagnostic capabilities, from patient treatment to pathogen detection. We welcome the opportunity to showcase our vision and technology to the many investors and industry leaders at the Rodman & Renshaw Global Investment Conference."

About SuperNova Diagnostics®, Inc.

SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Media Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando
(212) 827-0020
jrando@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China
2. SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13
3. Dilon Diagnostics® Partners With PenRad®
4. Thoratec Announces Presentations at Upcoming Investor Conferences
5. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
6. Access Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference on Monday, September 12th in New York City
7. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12
8. Golden Meditech Celebrates Grand Opening of Taiwan Representative Office
9. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
10. Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
11. Amgen to Present at the Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... --  Fourth-quarter 2016 revenues of ... to top end of guidance ... in fourth-quarter 2016 associated with the write-down of goodwill ... reporting unit Fourth-quarter reported ... Full-year 2016 reported $14.48 diluted (GAAP) loss per share ...
(Date:2/27/2017)... 27, 2017 Mederi Therapeutics today announced ... representing 2468 patients who received  Stretta Therapy  to ... " Systematic Review and Meta-Analysis of Controlled and ... Treatment of Gastroesophageal Reflux Disease ", was published in ... Fass , MD, head of the Esophageal and ...
(Date:2/27/2017)... Feb. 27, 2017   Vitasome ® Labs ... supplements using its groundbreaking new liposome technology. Whereas vitamins ... potency through digestion per Physician,s Desk Reference , ... problem of nutritional waste and are scientifically formulated to: ... processes Improve bioavailability with a vastly ...
Breaking Medicine Technology:
(Date:2/28/2017)... ... , ... BrightStar Care Marietta announced that it has received the 2017 Best ... is granted only to top-ranking home care providers, based on client satisfaction scores gathered ... care providers from across the country who have proven their ability to provide the ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... care industry, announces Chris Brandl as its New Guest Director. , Brandl ... to corporations throughout his career. He began his professional career at Omnium Worldwide, ...
(Date:2/27/2017)... Ohio (PRWEB) , ... February 27, 2017 , ... Elisa Guajardo Carothers is not your ... Life” to studying to become a nun. Now, she writes about God, when she isn’t ... “You Know BC and AD, Here is BS! (Before Satan),” she offers a comedic look ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... threshold mark last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count ... in March 2014. The company had 800 customers and 2,250 RCEs at the ...
(Date:2/26/2017)... (PRWEB) , ... February 25, 2017 , ... The February ... Jong-un, heightened awareness and concern over nerve agents and the deadly use of chemical ... human nervous system and how even small doses can be lethal. , Jay Jagannathan, ...
Breaking Medicine News(10 mins):